Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)

NCT03635424 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

NCT NCT03635424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03635424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Lead sponsor
Medtronic Cardiovascular
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 30, 2018
Completion date
December 31, 2030
Enrollment
150 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

bicuspid aortic valve